James S. Hanson
CIK 1744887 · General Counsel · last filed 2025-09-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$315.0K
Companies
3
Total Filings
19
Lifetime Open-Market Net
$51.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FTRE | General Counsel | 19,117 | $16.48 | $315.0K | $14.5K | 9 | 2025-09-10 |
| Fortrea Holdings Inc. (FTREV) Delisted | General Counsel | 25 | — | — | $0 | 1 | 2023-06-21 |
| G1 Therapeutics, Inc. (GTHX) Delisted | General Counsel | 41,816 | $7.15 | $299.0K | $37.3K | 9 | 2023-01-05 |
Recent Filings · Page 2 of 2
19 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-01-05 | G1 Therapeutics, Inc. (GTHX) Delisted | Mixed | +15,532 | -$13.1K | EDGAR |
| 2022-01-05 | G1 Therapeutics, Inc. (GTHX) Delisted | Mixed | +10,555 | -$15.3K | EDGAR |
| 2021-01-05 | G1 Therapeutics, Inc. (GTHX) Delisted | Grant (A) | +11,000 | $0 | EDGAR |
| 2020-09-08 | G1 Therapeutics, Inc. (GTHX) Delisted | Buy (P) | +1,000 | $14.9K | EDGAR |
| 2020-02-07 | G1 Therapeutics, Inc. (GTHX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-01-02 | G1 Therapeutics, Inc. (GTHX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-12-27 | G1 Therapeutics, Inc. (GTHX) Delisted | Buy (P) | +1,000 | $18.2K | EDGAR |
| 2018-12-11 | G1 Therapeutics, Inc. (GTHX) Delisted | Buy (P) | +1,000 | $32.5K | EDGAR |
| 2018-06-27 | G1 Therapeutics, Inc. (GTHX) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–19 of 19
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.